ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 7

Lamin A Deregulation in Human Mesenchymal Stem Cells Promotes an Impairment in Their Chondrogenic Potential and Imbalance in Their Response to Oxidative Stress

Jesus Mateos1, Alexandre De La Fuente2, Ivan A. Lesende-Rodriguez2, Maria Carmen Arufe2 and Francisco J. Blanco1, 1Rheumatology Division, Proteomics Unit-ProteoRed/ISCIII, INIBIC-Hospital Universitario A Coruña, A Coruña, Spain, 2Department of Medicine, Area of Anatomy and Human Embryology, University of A Coruña-INIBIC, A Coruña, Spain

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Mesenchymal stem cells and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint

Session Type: Abstract Submissions (ACR)

Background/Purpose: Previous work by our group and others indicated that an accumulation of lamin A (LMNA) was associated with the osteoarthritis (OA) chondrocyte phenotype. Mutations of this protein are linked to laminopathies and specifically to Hutchinson-Guilford Progeria Syndrome (HGPS), an accelerated aging disease. Some authors have proposed that a deregulation of LMNA affects the differentiation potential of stem cells. In the present study, we examined the effect of the over-expression of LMNA, or its mutant form progerin (PG), on the mesoderm differentiation potential of MSCs.

Methods: Mesenchymal stem cells (MSCs) from human umbilical cord (UC) stroma have previously been isolated, expanded and differentiated towards mesoderm cell lineages. For efficient gene delivery of wt LMNA, PG and GFP (Green Fluorescence Protein), we used a lentiviral expression system. GFP-transduced MSCs were used as control for the differentiation study since they present a differentiation capacity similar to that of untransduced MSCs. Osteogenic potential was studied by with alizarin red staining to assess calcium deposits as well as Real-Time PCR of ALP, OC and Runx2 to assess early and late osteogenic differentiation. Adipogenic potential was studied with Oil Red staining for lipid droplets and Real-Time PCR of LPL, FABP and ADIPOQ, for early and late adipogenic differentiation. Chondrogenesis and hypertrophy were studied using immunohistochemestry and Real-Time PCR of Aggrecan, MMP-13, Type II Collagen, Type I Collagen and Type I Collagen.

Results: We found that over-expression of LMNA or PG by lentiviral gene delivery leads to defects in differentiation potential. PG-transduced MSCs present defects in adipogenic and osteogenic potential, The chondrogenic potential is defective in PG-MSCs, which present a decrease in COL2 and Aggrecan as revealed by both immunohistochemystry and Real-Time PCR. LMNA and PG-transduced MSCs have an increase in hypertrophy markers (MMP-13 and Type X Collagen) during chondrogenic differentiation, as well as a decrease in manganese superoxide dismutase (MnSODM) and an increase of mitochondrial MnSODM-dependent reactive oxygen species (ROS). ROS synthesis was partially (51%) and totally reverted by N-Acetyl Cystein, ROS scavenger, (NAC) at 20 and 40 µg/mL respectively for 1 hour in culture. In addition, defects in chondrogenesis detected by immunohistochemestry and Real Time-PCR are partially reversed by incubations with NAC at 40 µg/mL for 1 hour.

Conclusion: Our results suggest that OA process could be enhanced by defects in stem cell differentiation, partially due to imbalance in oxidative stress.


Disclosure:

J. Mateos,
None;

A. De La Fuente,
None;

I. A. Lesende-Rodriguez,
None;

M. C. Arufe,
None;

F. J. Blanco,
None.

  • Tweet
  • Email
  • Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/lamin-a-deregulation-in-human-mesenchymal-stem-cells-promotes-an-impairment-in-their-chondrogenic-potential-and-imbalance-in-their-response-to-oxidative-stress/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology